Prenetics Global Limited (NASDAQ:PRE) Sees Significant Growth in Short Interest

Prenetics Global Limited (NASDAQ:PREGet Free Report) saw a significant growth in short interest during the month of September. As of September 30th, there was short interest totalling 31,200 shares, a growth of 352.2% from the September 15th total of 6,900 shares. Based on an average daily volume of 19,400 shares, the short-interest ratio is currently 1.6 days. Approximately 0.4% of the company’s stock are sold short.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Prenetics Global stock. Nomura Holdings Inc. grew its position in Prenetics Global Limited (NASDAQ:PREFree Report) by 140.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 193,963 shares of the company’s stock after buying an additional 113,288 shares during the quarter. Nomura Holdings Inc. owned 2.12% of Prenetics Global worth $1,146,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 25.01% of the company’s stock.

Prenetics Global Stock Up 7.7 %

Shares of NASDAQ PRE traded up $0.30 during mid-day trading on Thursday, hitting $4.18. 7,571 shares of the company were exchanged, compared to its average volume of 58,100. The stock has a 50 day simple moving average of $4.79 and a 200-day simple moving average of $5.13. Prenetics Global has a 1-year low of $2.85 and a 1-year high of $7.84. The firm has a market cap of $38.19 million, a price-to-earnings ratio of -0.94 and a beta of -0.16.

About Prenetics Global

(Get Free Report)

Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies.

Read More

Receive News & Ratings for Prenetics Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prenetics Global and related companies with MarketBeat.com's FREE daily email newsletter.